Health claims here span coffee and heart risk, estrogen clearance and muscle mass, AI cancer imaging, and contested origins of COVID-19.
424 Health claim verifications avg. score 4.8/10 140 rated true or mostly true 284 rated false or misleading
“Pancreatic proteases such as trypsinogen and chymotrypsinogen are synthesized as inactive zymogens and are activated in the duodenum by an intestinal enzyme (enterokinase/enteropeptidase), which helps prevent autodigestion of the pancreas.”
The claim matches standard human physiology. Pancreatic proteases are secreted as inactive precursors, and enteropeptidase in the duodenum initiates their activation by converting trypsinogen to trypsin, which then activates other zymogens. Delaying activation until the intestine is an important safeguard against pancreatic autodigestion, though not the only one.
“During emulsification in digestion, each microscopic fat droplet contains only fat in its interior, bile salts form a protective outer layer with their lipophilic ends facing inward and hydrophilic ends facing outward, and water is located entirely outside the droplet surrounding it.”
The claim captures the basic orientation of bile salts at a fat-water interface, but it oversimplifies the actual structure of digestive emulsions. In the intestine, droplet surfaces are usually mixed layers of bile salts and phospholipids, and droplet interiors are not strictly pure fat. This is a useful teaching model, not an accurate literal description of every emulsified droplet.
“Consuming sugary drinks before midnight makes babies hyperactive and less likely to fall asleep at their usual bedtime.”
The evidence does not support this claim. Research and pediatric guidance do not show that sugar itself makes babies acutely hyperactive, and the better-supported sleep concern in sweet drinks is caffeine, not sugar alone. The claim also invents a "before midnight" cutoff and extends findings from older children or long-term observational studies to babies and same-night bedtime effects without evidence.
“Reduced perfusion of the small-intestinal mucosa can impair enterocyte renewal and contribute to villous blunting (villous atrophy), reducing absorptive surface area.”
Evidence supports this mechanism. Reduced small-intestinal mucosal perfusion can impair epithelial renewal, promote enterocyte loss, and contribute to villous blunting, which lowers absorptive surface area. The strongest data come from ischemia, shock, and sustained hypoperfusion models, but the claim is appropriately cautious in saying this can occur and can contribute.
“During an acute stress response, splanchnic vasoconstriction reduces gastrointestinal perfusion and prioritizes blood flow to the heart, lungs, and skeletal muscle.”
The statement captures the main physiology: acute sympathetic activation constricts the splanchnic circulation, lowering gastrointestinal blood flow and helping preserve perfusion for the heart and active skeletal muscle. The weak point is "lungs": pulmonary flow usually rises because cardiac output rises, not because blood is selectively diverted there. Many references also emphasize preservation of brain perfusion and arterial pressure.
“Villous blunting can reduce intestinal absorption of nutrients including glucose, amino acids, and fat-soluble vitamins.”
The evidence supports the claim. Villous blunting decreases absorptive surface and functional capacity in the small intestine, which can reduce absorption of glucose, amino acids, and fats; fat-soluble vitamin deficits commonly follow from impaired fat absorption. Severity varies by how extensive the villous damage is, but the basic statement is accurate.
“Physiologic stress can increase intestinal permeability by disrupting tight junctions between enterocytes, which increases translocation of luminal antigens and bacteria.”
The literature strongly supports that stress can impair the intestinal barrier by altering tight-junction function and increasing permeability. Reviews, animal studies, and cell studies also link this barrier disruption to greater passage of luminal antigens and, in some models, bacteria. The main caveat is that the full causal chain is demonstrated most directly in animal and in vitro research; human evidence is stronger for permeability changes than for direct bacterial translocation.
“During acute stress, pulmonary blood flow increases mainly because cardiac output increases.”
The central mechanism is correct for typical acute stress in healthy people: sympathetic activation raises cardiac output, and pulmonary blood flow usually rises with it. The statement becomes too broad if applied to all stressors or all patients, because acute hypoxia and diseases such as severe pulmonary hypertension can make pulmonary vascular resistance or right-heart afterload more important.
“After proteases finish digesting food in the duodenum, they move with chyme into the middle and distal small intestine and then digest themselves and other enzymes into amino acids.”
Reliable physiology sources show that pancreatic proteases do travel through the small intestine and are progressively inactivated and degraded there. But the claim misstates the sequence and emphasis: protein digestion does not simply end in the duodenum, and distal enzyme breakdown is not shown to be the main or intended next step. It blends a real phenomenon with an overstated physiological narrative.
“Most intestinal juice in the small intestine comes from the contents released when small-intestinal epithelial cells rupture and slough off, rather than from fluid actively secreted by intestinal glands.”
The evidence does not support the claim. Authoritative physiology sources describe intestinal juice as mainly water and electrolytes actively secreted by crypt epithelium and glands, not fluid released from ruptured, sloughed cells. The main cited support concerns protein content in cellular debris from an older animal study, which does not establish that most intestinal juice volume comes from cell shedding.
“Under normal conditions, only a very small fraction of dietary amino acids in the small-intestinal lumen are diverted by other substances or are consumed by colonic bacteria before being absorbed, so amino-acid loss is very low.”
Most dietary amino acids are absorbed in the small intestine under normal, healthy conditions, so losses before absorption are generally low. Human studies and reviews commonly report ileal amino-acid digestibility above 90%, often above 95%. The wording is somewhat broad because digestibility differs by protein source and some proteinaceous material still reaches the colon, but that does not overturn the main conclusion for typical diets.
“In humans, taste buds that detect sweet taste are concentrated at the tip of the tongue.”
The evidence does not support a sweet-specific cluster of taste buds at the tongue tip. Modern taste research has rejected the old textbook “tongue map”: sweet-responsive cells are found across multiple tongue regions, with only minor regional sensitivity differences at most. Those sensitivity differences do not mean sweet-detecting taste buds are concentrated at the tip.
“Drinking coffee stains teeth yellow.”
Coffee is a well-established cause of extrinsic tooth staining, and the discoloration often appears yellow-brown over time. The evidence from dental studies is strong, but the effect is not uniform or inevitable for every coffee drinker. Staining depends on exposure, enamel condition, and oral hygiene, and some studies use lab conditions that can overstate real-world effects.
“Eating chocolate cures depression.”
The evidence does not support chocolate as a cure for depression. Some studies suggest small, short-term mood improvements from cocoa-rich products, but they do not show that eating chocolate resolves diagnosed depressive disorder or provides lasting clinical recovery. Major health authorities and systematic reviews do not endorse chocolate as a treatment for depression.
“Among patients 12 months after ST-elevation myocardial infarction, those with high-sensitivity C-reactive protein levels greater than 26.4 mg/L had a 12% rate of major adverse cardiovascular events, compared with a 4% rate among those with high-sensitivity C-reactive protein levels at or below 26.4 mg/L.”
The quoted 12% versus 4% event rates are supported by a 2024 peer-reviewed STEMI study. However, those numbers came from a selected cohort followed for about 12 months, and the 26.4 mg/L threshold was the study’s median hs-CRP level, not a broadly accepted universal cutoff. The data are accurate, but the wording is slightly broader than the underlying evidence.
“A prospective Fudan University study of 724 patients with recent myocardial infarction found that soluble interleukin-2 receptor (sIL-2R) was an independent predictor of long-term major adverse cardiac events, reporting an unadjusted hazard ratio of 9.123 (95% CI 5.883–14.147) and an adjusted hazard ratio of 3.761 (95% CI 2.269–6.233) with p < 0.001.”
The cited study details are supported by the published record. Multiple authoritative versions of the same Fudan/Zhongshan cohort paper report 724 patients, a prospective design, and the exact unadjusted and adjusted hazard ratios with p<0.001. The main caveat is a likely misindexed older database entry, plus the study’s single-center design and cutoff-based analysis.
“A follow-up study of 382 adults younger than 60 years old, assessed 3 months after a first myocardial infarction and followed for 20 years, reported that participants in the highest tertile of interleukin-6 had a 2.70-fold higher risk of hospitalization for heart failure than those in the lowest tertile (hazard ratio 2.70; 95% CI 1.32–5.50).”
The reported hazard ratio appears in the literature, but the claim’s age-specific framing is not reliably established. One abstract describes 382 adults younger than 60, yet other peer-reviewed sources assign the same 2.70 estimate and sample to patients aged 60–74, and a related report cites 391 participants. Because age materially affects interpretation, the statement overstates certainty about which cohort produced this result.
“Creatine supplementation reduces S-adenosylmethionine (SAMe) demand by decreasing endogenous creatine synthesis.”
Available evidence supports this mechanism. Creatine supplementation suppresses endogenous creatine synthesis, and that synthesis normally uses SAMe to methylate guanidinoacetate into creatine, so the pathway’s SAMe demand falls. Unchanged blood SAM, SAH, or homocysteine in some trials does not negate this, because those markers do not directly measure pathway flux.
“Creatine supplementation improves brain fog in humans.”
Creatine may help some cognitive functions linked to what people call brain fog, but the evidence does not directly show that it generally improves “brain fog” in humans. Most studies measured objective cognitive tasks, not the symptom itself, and positive effects are most apparent in specific settings such as sleep deprivation, older adults, or other higher-demand conditions. The broad, unqualified wording goes beyond the evidence.
“Bipolar disorder is characterized by episodes of mania or hypomania and episodes of depression.”
This is a generally accurate description of bipolar disorder, but it is not a universal diagnostic rule. Major medical sources describe bipolar disorder as involving periods of mania or hypomania and depression, yet Bipolar I can be diagnosed without any prior depressive episode. The claim is best read as a broad characterization rather than a strict criterion.